References

1. SperoffL, Fritz MA. Clinical Gynecologic Endocrinology and Infertility. 7th ed. Philadelphia: Lippincott Williams & Wilkins, 2005:187-232, 401-463.

2. Reindollar RH, Novak M, Tho SP, McDonough PG. Adult-onset amenorrhea: A study of 262 patients. Am J Obstet Gynecol 1986;155(3):531-543.

3. Barbeiri RL, Ryan KJ. The menstrual cycle. In: Ryan Kistner's Gynecology and Women's Health. 7th ed. St. Louis, MO: Mosby, 1999:23-57.

4. Stenchever MA, Droegemueller W, Herbst AL, Mishell DR. Abnormal uterine bleeding: Ovulatory and anovulatory dysfunctional uterine bleeding, management of acute and chronic excessive bleeding. In: Comprehensive Gynecology. 4th ed. St. Louis, MO: Mosby, 2001:1079-1097.

5. American College of Obstetricians and Gynecologists. Management of anovulatory bleeding. ACOG Practice Bulletin Number 14. Obstet Gynecol 2000(Mar):495-502.

6. SperoffL, Glass RH, KaseNG. Clinical gynecologic endocrinology and infertility. 6th ed. Baltimore, MD: Lippincott Williams & Wilkins, 1999:487-511.

7. American College of Obstetricians and Gynecologists. Polycystic ovary syndrome. ACOG Practice Bulletin Number 41. Obstet Gynecol 2002;100:1389-1402.

8. Adams Hillard PJ, Deitch HR. Menstrual disorders in the college age female. Pe-diatr Clin N Am 2005;52(1):179-197.

9. Gordon CM, Nelson LM. Amenorrhea and bone health in adolescents and young women. Curr Opin Obstet Gynecol 2003;15:377-384.

10. Pletcher JR, Slap GB. Menstrual disorders—Amenorrhea. Pediatr Clin N Am 1999;46(3):505-518.

11. French L. Dysmenorrhea. Am Fam Physician 2005;71:285-292.

12. Roy SN, Bhattacharya S. Benefits and risks of pharmacological agents used for the treatment of menorrhagia. Drug Safety 2004;27(2):75-90.

13. Munro MG, Mainor N, Basu R, et al. Oral medroxyprogesterone acetate and combination oral contraceptives for acute uterine bleeding: A randomized clinical trial. Obstet Gynecol 2006;108:924-929.

14. Harel Z. A contemporary approach to dysmenorrhea in adolescents. Pediatr Drugs 2002;4(12):797-805.

15. Simon JA. Progestogens in the treatment of secondary amenorrhea. J Reprod Med 1999;44:185-189.

16. Warner PE, Critchley HO, Lumsden MA, et al. Menorrhagia I: Measured blood loss, clinical features, and outcome in women with heavy periods: A survey with follow-up data. Am J Obstet Gynecol 2004;190(5):1216-1223.

17. Warner PE, Critchley HO, Lumsden MA, et al. Menorrhagia II: Is the 80-mL blood loss criterion useful in management of complaint of menorrhagia? Am J Obstet Gynecol 2004;190(5):1224-1229.

18. Dickersin K, Munro MG, Clark M, et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding: A randomized controlled trial. Obstet Gynecol 2007;110(6):1279-1289.

19. Prentice A. Fortnightly review: Medical management of menorrhagia. BMJ 1999;319(7221):1343-1345.

20. Reid PC, Virtanen-Kari S. Randomized comparative trial of levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: A multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts. Br J Obstet Gynecol 2005;112:1121-1125.

21. American College of Obstetricians and Gynecologists. Noncontraceptive uses of the levonorgestrel intrauterine system. ACOG Committee Opinion Number 337. Obstet Gynecol 2006(June);107:1479-1482.

22. American College of Obstetricians and Gynecologists. Intrauterine device. ACOG Practice Bulletin No. 59. Obstet Gynecol 2005;105:223-232.

23. Hurskainen R, Paavonen J. Levonorgestrel-releasing intrauterine system in the treatment of heavy menstrual bleeding. Curr Opin Obstet Gynecol 2004;16:487-490.

24. Hurskainen R, Teperi J, Rissanen P, et al. Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment ofmen-orrhagia: Randomized trial 5-year follow-up. JAMA 2004;291(12):1456-1463.

25. Dawood MY. Primary dysmenorrhea: Advances in pathogenesis and management. Obstet Gynecol 2006;108:428-441.

26. Stenchever MA, Droegemueller W, Herbst AL, Mishell DR. Primary and secondary dysmenorrhea and premenstrual syndrome etiology, diagnosis, and management. In: Stenchever MA, ed. Comprehensive Gynecology. 4th ed. St. Louis, MO: Mosby, 2001:1065-1078.

27. American College of Obstetricians and Gynecologists. Menstruation in girls and adolescents: Using the menstrual cycle as a vital sign. ACOG Committee Opinion Number 349. American Academy of Pediatrics; American College of Obstetricians and Gynecologists. Obstet Gynecol 2006(Nov);108:1323-1328.

28. Guzick DS. Polycystic ovary syndrome. Am J Obstet Gynecol 2004;103(1):181-192.

29. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81(1):19-25.

30. Buggs C, Rosenfield, RL. Polycystic ovary syndrome in adolescence. Endocrinol Metab Clin N Am 2005;34:677-705.

31. Mathur R, Levin O, Azziz R. Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome. Ther Clin Risk Manag 2008;4(2):487-492.

32. Creanga AA, Bradley HM, McCormick C, et al. Use of metformin in polycystic ovary syndrome: A meta-analysis. Obstet Gynecol 2008;111(4):959-968.

33. Khorram O, Helliwell JP, Katz S, et al. Two weeks of metformin improves clomi-phene citrate-induced ovulation and metabolic profiles in women with polycystic ovary syndrome. Fertil Steril 2006;85(5):1448-1451.

Pregnancy Guide

Pregnancy Guide

A Beginner's Guide to Healthy Pregnancy. If you suspect, or know, that you are pregnant, we ho pe you have already visited your doctor. Presuming that you have confirmed your suspicions and that this is your first child, or that you wish to take better care of yourself d uring pregnancy than you did during your other pregnancies; you have come to the right place.

Get My Free Ebook


Post a comment